Embecta Corp. reports results for the quarter ended June 30 - Earnings Summary

Embecta

07/08/2026 14:31

Embecta Corp. EMBC.OQ reported quarterly adjusted earnings of 56 cents​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of $1.12.  The mean expectation of four analysts for the quarter was for earnings of 27 cents per share. Wall Street expected results to range from 25 cents to 29 cents per share.
Revenue fell 8.1% to $271.70 million from a year ago; analysts expected $254.53 million. 
Embecta Corp.'s reported EPS for the quarter was 36 cents​.
The company reported quarterly net income of $21.1 million.
Embecta Corp. shares had risen by 7.4% this quarter and lost 70.5% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 34.6% in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 3 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is  "buy."
Wall Street's median 12-month price target for Embecta Corp. is $5.00, about 30% above its last closing price of $3.50
This summary was machine generated from LSEG data August 7 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
0.27
0.56
Beat
Mar. 31 2026 
0.42
0.27
Missed
Dec. 31 2025 
0.67
0.71
Beat
Sep. 30 2025 
0.54
0.50
Missed